Search details
1.
Cannabidiol Inhibits the Proliferation and Invasiveness of Prostate Cancer Cells.
J Nat Prod
; 86(9): 2151-2161, 2023 09 22.
Article
in English
| MEDLINE | ID: mdl-37703852
2.
Role of serum response factor expression in prostate cancer biochemical recurrence.
Prostate
; 78(10): 724-730, 2018 07.
Article
in English
| MEDLINE | ID: mdl-29608018
3.
Abnormal cell-clearance and accumulation of autophagic vesicles in lymphocytes from patients affected with Ataxia-Teleangiectasia.
Clin Immunol
; 175: 16-25, 2017 02.
Article
in English
| MEDLINE | ID: mdl-27915003
4.
Relationship between serum response factor and androgen receptor in prostate cancer.
Prostate
; 75(15): 1704-17, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26250344
5.
The analysis of serum response factor expression in bone and soft tissue prostate cancer metastases.
Prostate
; 74(3): 306-13, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24249383
6.
Case report: EBV-related eye orbits and sinuses lymphohistiocytic infiltration responsive to rituximab in a patient with X lymphoproliferative syndrome type 1.
Front Immunol
; 15: 1370991, 2024.
Article
in English
| MEDLINE | ID: mdl-38633254
7.
Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?
Prostate
; 73(7): 743-53, 2013 May.
Article
in English
| MEDLINE | ID: mdl-23359479
8.
Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
J Pathol
; 226(5): 746-55, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-22069160
9.
SRF inhibitors reduce prostate cancer cell proliferation through cell cycle arrest in an isogenic model of castrate-resistant prostate cancer.
Cell Cycle
; 22(14-16): 1759-1776, 2023.
Article
in English
| MEDLINE | ID: mdl-37377210
10.
The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines.
Proteomics
; 12(13): 2115-26, 2012 Jul.
Article
in English
| MEDLINE | ID: mdl-22623417
11.
Emerging role for the Serum Response Factor (SRF) as a potential therapeutic target in cancer.
Expert Opin Ther Targets
; 26(2): 155-169, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35114091
12.
Evaluation of a Real-time PCR in Combination with a Cultivation Method for the Detection of Brucella Abortus in Organs of Infected Cattle in Southern Italy.
J Vet Res
; 66(4): 559-563, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36846044
13.
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines.
Mol Cancer
; 10: 126, 2011 Oct 07.
Article
in English
| MEDLINE | ID: mdl-21982118
14.
Sub-Toxic Concentrations of Ionic Liquids Enhance Cell Migration by Reducing the Elasticity of the Cellular Lipid Membrane.
J Phys Chem Lett
; 11(17): 7327-7333, 2020 Sep 03.
Article
in English
| MEDLINE | ID: mdl-32794718
15.
Clinical Phenotype, Immunological Abnormalities, and Genomic Findings in Patients with DiGeorge Spectrum Phenotype without 22q11.2 Deletion.
J Allergy Clin Immunol Pract
; 8(9): 3112-3120, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32668295
16.
Inhibition of Serum Response Factor Improves Response to Enzalutamide in Prostate Cancer.
Cancers (Basel)
; 12(12)2020 Nov 27.
Article
in English
| MEDLINE | ID: mdl-33260953
17.
Novel Strategies for Cancer Treatment: Highlights from the 55th IACR Annual Conference.
Cancers (Basel)
; 11(8)2019 Aug 07.
Article
in English
| MEDLINE | ID: mdl-31394729
18.
Innovative Technologies Changing Cancer Treatment.
Cancers (Basel)
; 10(6)2018 Jun 19.
Article
in English
| MEDLINE | ID: mdl-29921753
19.
Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma.
Cancer Lett
; 254(2): 298-307, 2007 Sep 08.
Article
in English
| MEDLINE | ID: mdl-17498870
20.
The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
Mol Oncol
; 11(3): 251-265, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28133913